U.S. Intravenous Immunoglobulin (IVIG) Market To Exhibit At A CAGR Of 6.1% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.
San Francisco, 27 May 2019: The Report U.S. Intravenous Immunoglobulin (IVIG) Market Size, Share & Trends Analysis Report By Application (CIDP, Congenital AIDS), By Route of Administration (IV, Subcutaneous), By Distribution Channel, And Segment Forecasts, 2018 – 2025 The U.S. Intravenous Immunoglobulin (IVIG) Market size is expected to reach USD 5.04 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a noteworthy CAGR of 6.1% over the forecast period. Rising prevalence of primary and acquired immunodeficiency diseases such as congenital AIDS and hypogammaglobulinemia is a major growth driver of this market. Rising cases of primary immune deficiency diseases are expected to drive the demand for fast, accurate, and safe treatment options, thereby boosting the market growth. Other IVIG applications, such as neurological disorders, organ transplantation, peripheral neuropathies, and Alzheimer’s disease, also provide a luc